Variant report
Variant | nsv613296 |
---|---|
Chromosome Location | chr9:8640921-8641791 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs143757960 | chr9:8640928-8640929 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs151078660 | chr9:8640961-8640962 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs376603702 | chr9:8640966-8640967 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs369079292 | chr9:8641013-8641014 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs531380276 | chr9:8641071-8641072 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs551606685 | chr9:8641103-8641104 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs549211186 | chr9:8641108-8641109 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs183814797 | chr9:8641113-8641114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs547772181 | chr9:8641114-8641115 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs142640662 | chr9:8641126-8641127 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539916604 | chr9:8641128-8641129 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188406239 | chr9:8641191-8641192 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35286414 | chr9:8641207-8641208 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs193014328 | chr9:8641226-8641227 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs146895968 | chr9:8641262-8641263 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10114687 | chr9:8641304-8641305 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs199786456 | chr9:8641307-8641308 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184859627 | chr9:8641357-8641358 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs537607686 | chr9:8641423-8641424 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs576653534 | chr9:8641519-8641520 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs113071195 | chr9:8641577-8641578 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs562388219 | chr9:8641600-8641601 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs138674591 | chr9:8641630-8641631 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs574101735 | chr9:8641651-8641652 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs570521650 | chr9:8641665-8641666 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72698277 | chr9:8641763-8641764 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs559891402 | chr9:8641771-8641772 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142688074 | chr9:8641775-8641776 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Intracranial aneurysm | 16715129 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Disorders of sex development | 22290220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21183584 | CNVD |
Non-small cell lung cancer | 21952639 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Intellectual disability | 22102821 | CNVD |
abnormal development | 18461090 | CNVD |
Honadal dysgenesis | 21048976 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lung cancer | 16740712 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 16608533 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 16272173 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Cervical cancer | 21063398 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Melanoma | 18172304 | CNVD |
Biliary cancer | 19435499 | CNVD |
Gastric cancer | 21586687 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myopathy | 18421352 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Acute lymphoblastic leukemia | 18957548 | CNVD |
Myeloproliferative neoplasm | 17564968 | CNVD |
Malignant meningioma | 17937814 | CNVD |
Glioma | 21971842 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chordoma | 21602918 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Developmental delay | 19490664 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
microdeletion syndrome | 16199537 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Cancer | 20164919 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Non-syndromic sensorineural hearing loss | 21030649 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Developmental delay | 21147756 | CNVD |
Lung cancer | 18438408 | CNVD |
XY gonadal dysgenesis | 20685758 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Oral cancer | 21386901 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21858162 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Autism | 22495311 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Breast cancer | 21364760 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Glioblastoma | 19074898 | CNVD |
Malignant melanoma | 19074898 | CNVD |
Prostate cancer | 16573809 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Lung cancer | 20668451 | CNVD |
Schizophrenia | 20838587 | CNVD |
Glioblastoma | 18772890 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20858261 | CNVD |
Epilepsy | 20858261 | CNVD |
Mental retardation | 20858261 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr9:8616800-8648000 | Weak transcription | Fetal Kidney | kidney |
2 | chr9:8622000-8648600 | Weak transcription | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
3 | chr9:8623400-8647800 | Weak transcription | Primary hematopoietic stem cells | blood |
4 | chr9:8628400-8643600 | Weak transcription | Fetal Muscle Leg | muscle |
5 | chr9:8628800-8644000 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
6 | chr9:8628800-8644200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
7 | chr9:8629800-8651600 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
8 | chr9:8630200-8652400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
9 | chr9:8631000-8649800 | Weak transcription | Ovary | ovary |
10 | chr9:8633200-8644200 | Weak transcription | Brain Inferior Temporal Lobe | brain |
11 | chr9:8634000-8641000 | Weak transcription | Fetal Lung | lung |
12 | chr9:8634200-8643800 | Weak transcription | Brain Hippocampus Middle | brain |
13 | chr9:8634600-8648000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr9:8636600-8643400 | Weak transcription | Fetal Muscle Trunk | muscle |
15 | chr9:8638000-8648000 | Weak transcription | Fetal Brain Male | brain |
16 | chr9:8640800-8641800 | Enhancers | Fetal Heart | heart |
17 | chr9:8641000-8641200 | Enhancers | Fetal Lung | lung |